(Q46748903)

24 December 2017

title

Inhibitory effect of minocycline on amyloid beta fibril formation and human microglial activation (English)

1 reference

24 December 2017

1 reference

1 reference

Atoosa Familian

1

1 reference

24 December 2017

Ronald S Boshuizen

series ordinal

2

1 reference

24 December 2017

Piet Eikelenboom

series ordinal

3

1 reference

24 December 2017

Robert Veerhuis

series ordinal

4

1 reference

24 December 2017

publication date

1 February 2006

1 reference

24 December 2017

published in

Glia

1 reference

24 December 2017

volume

53

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

page(s)

233-240

1 reference

24 December 2017

Evaluation of the hepatotoxic potential of minocycline

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

Microglia, amyloid and dementia in alzheimer disease. A correlative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

In vitro response of human gingival epithelioid S-G cells to minocycline

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Clinical potential of minocycline for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Neuroprotection in Huntington's disease: a 2-year study on minocycline

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

An in vitro screening assay based on synthetic prion protein peptides for identification of fibril-interfering compounds.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

In-vivo measurement of activated microglia in dementia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

In vitro modulation of epidermal inflammatory cytokines (IL-1 alpha, IL-6, TNF alpha) by minocycline

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Liquid chromatographic determination of minocycline in brain-to-plasma distribution studies in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Anti-amyloidogenic activity of tetracyclines: studies in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Microglia in neurodegeneration: molecular aspects

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Safety of long-term high-dose minocycline in the treatment of acne

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Microglia as a source and target of cytokines

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Clinical pharmacokinetics of doxycycline and minocycline

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Microglial activation in early stages of amyloid beta protein deposition.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Minocycline and doxycycline are not beneficial in a model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Minocycline in Huntington's disease: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20268

7 January 2021

Identifiers

DOI

10.1002/GLIA.20268

1 reference

24 December 2017

1 reference

24 December 2017